"I don't know how she's doing in the nomination process. I'm more focused on Iran," Trump told reporters. When pressed on whether he might pull the nomination, he added: "But, you know, something like that would be possible. We certainly have a lot of... great candidates."

The comments mark an unusual public hedge from a president who typically defends his nominees until the moment he doesn't. They land after months of turbulence around the surgeon general slot, a position that was already on its second nominee before Means even sat for her hearing.

A nomination born from a previous withdrawal

Means was not Trump's first choice. His original pick, Dr. Janette Nesheiwat, a former Fox News contributor, was sidelined following questions about her credentials. The New York Post reported that Trump pulled Nesheiwat's nomination just one day before her scheduled confirmation hearing, announcing Means as the replacement. White House sources told the Post that Nesheiwat had faced strong opposition from supporters of the Make America Healthy Again movement, anti-COVID-vaccine activists, and frontline doctors.

Trump framed the switch as a natural fit. "I am pleased to announce that Dr. Casey Means, will be nominated as our next Surgeon General of the United States of America," he posted on Truth Social at the time. He described Means as having "impeccable 'MAHA' credentials."

The Washington Examiner reported that Nesheiwat had drawn criticism from conservative activist Laura Loomer over how she described her medical credentials, including claims about being double board-certified and attending the University of Arkansas School of Medicine. Trump said at the time that Health and Human Services Secretary Robert F. Kennedy Jr. "looks forward to working with Dr. Janette Nesheiwat in another capacity at HHS."

So Means entered the picture as the candidate who was supposed to clear the path. She didn't.

A confirmation hearing delayed, then fraught

A scheduled confirmation hearing in 2025 was postponed after Means went into labor. When she eventually appeared before the Senate Committee on Health, Education, Labor and Pensions in February, the session raised more questions than it answered for skeptical Republicans.

Means acknowledged during her testimony that vaccines save lives. But she stopped short of fully endorsing certain federal vaccine recommendations, including those related to measles. For a nominee whose appeal rested on her alignment with the MAHA movement's skepticism of the medical establishment, the hedging was predictable. For Republican senators who needed cover to vote yes, it was a problem.

Sen. Susan Collins of Maine questioned Means about her admission that she has used psilocybin mushrooms, not the kind of biographical detail that smooths a Senate confirmation. Sen. Lisa Murkowski of Alaska has not yet publicly backed Means either. With Democrats on the committee firmly opposed, Means cannot afford to lose more than a handful of Republican votes.

And right now, she does not appear to have them locked down.

Resistance from inside the MAHA orbit

The opposition has not come only from cautious Senate moderates. Means has also faced pushback from within the broader Make America Healthy Again movement itself, the very constituency she was chosen to represent.

Nicole Shanahan, who served as Kennedy's running mate in the 2024 presidential election, has been outspoken on social media opposing both Casey Means and her brother, Calley Means. Calley Means serves as a White House senior adviser. The nature of Shanahan's specific objections was not detailed in available reporting, but the public opposition from a figure so closely tied to Kennedy's political orbit is notable.

When a nominee's own ideological allies are working against her on social media, the math on Capitol Hill gets harder, not easier.

What Trump's tone reveals

Presidents do not usually float the withdrawal of their own nominees in casual exchanges aboard Air Force One unless the ground has already shifted beneath the pick. Trump's phrasing, "We're looking at a lot of different things", is the language of a principal keeping his options open, not one preparing to fight for a confirmation.

He also noted that he has "a lot of great candidates," a line that reads less like reassurance and more like a preview of a replacement search. The surgeon general post has now consumed two nominees without a confirmed officeholder. The delays have left the position in limbo during a period when the administration's broader health agenda, driven by Kennedy at HHS, needs a public-facing advocate who can survive a Senate vote.

The core issue is straightforward. Means was chosen because she fit the MAHA brand. But the qualities that made her attractive to that movement, her skepticism of mainstream vaccine guidance, her unconventional health views, her personal history with controlled substances, are the same qualities that make moderate Republicans hesitate. The nominee's appeal and her vulnerability are the same thing.

A pattern worth watching

This is now the second surgeon general nominee to run into confirmation trouble under Trump. Nesheiwat was pulled over credential questions and pressure from the MAHA base. Means was elevated to satisfy that base and now faces resistance from senators who find her positions too far outside the mainstream.

The administration has a narrow Senate majority and a health agenda that depends on confirmed officials who can carry it forward. Every week the surgeon general slot sits empty is a week without a confirmed voice for that agenda. If Means is withdrawn, the next pick will face the same squeeze: satisfy the MAHA movement's expectations or satisfy enough Republican senators to clear committee and reach the floor.

Those two audiences have shown, twice now, that they want different things.

At some point, the administration will have to decide which audience it needs more, the online movement or the fifty votes. So far, it has managed to disappoint both.